Inactivating mutations of the histone acetyltransferase genes EP300 and CREBBP, were not associated with response in DLBCL cells (Supplementary Figure 4), which frequently harbor mutations of these genes [3, 4]. The gene discussed is EP300; the disease is diffuse large B-cell lymphoma.